(Q30740899)

26 June 2017

P53 autoantibodies in sera from Danish ovarian cancer patients and their correlation with clinical data and prognosis (English)

1 reference

26 June 2017

1 reference

1 reference

Estrid V S Høgdall

1

1 reference

26 June 2017

Claus K Høgdall

2

1 reference

26 June 2017

Jan Blaakaer

3

1 reference

26 June 2017

Niels H H Heegaard

4

1 reference

26 June 2017

Eva Glud

5

1 reference

26 June 2017

Lise Christensen

6

1 reference

26 June 2017

Johannes E Bock

7

1 reference

26 June 2017

Bent Nørgaard-Pedersen

8

1 reference

26 June 2017

Allan Wiik

9

1 reference

26 June 2017

Susanne K Kjaer

10

1 reference

26 June 2017

1 August 2002

1 reference

Acta Pathologica et Microbiologica Scandinavica

26 June 2017

1 reference

26 June 2017

110

1 reference

26 June 2017

545-553

1 reference

26 June 2017

7-8

1 reference

Cancer. p53, guardian of the genome

26 June 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

Characterization of the human p53 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

The old and the new in p53 functional regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

Role of tumour markers in monitoring epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

P53 autoantibodies in 1006 patients followed up for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

Circulating antibodies against p53 protein in patients with ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

7 January 2021

Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

7 January 2021

p53 autoantibodies in patients with primary ovarian cancer are associated with higher age, advanced stage and a higher proportion of p53-positive tumor cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

7 January 2021

Tribute to Patrick Steptoe: beginnings of laparoscopy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

7 January 2021

Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

7 January 2021

Evaluation of two new assays for tumor-associated antigens, CASA and OSA, found in the serum of patients with epithelial ovarian carcinoma—Comparison with CA125

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

7 January 2021

A combined approach for the early detection of ovarian cancer in asymptomatic women

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

7 January 2021

The role of serum tetranectin, CA 125, and a combined index as tumor markers in women with pelvic tumors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

7 January 2021

Serum tetranectin and CA-125 used to monitor the course of treatment in ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

7 January 2021

Estrogen- and androgen-responsive growth of human ovarian adenocarcinoma heterotransplanted into nude mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

7 January 2021

Serum p53 autoantibodies in the follow-up of head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

7 January 2021

Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.11007805.X

7 January 2021

10.1034/J.1600-0463.2002.11007805.X

Identifiers

DOI

1 reference

26 June 2017

1 reference